| Dr Cameron Lewis Jones, MD | |
|
155 N Fresno St, Fresno, CA 93701-2302 | |
| (559) 499-6440 | |
| Not Available |
| Full Name | Dr Cameron Lewis Jones |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 17 Years |
| Location | 155 N Fresno St, Fresno, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275779399 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A106303 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hosp So Sacramento | Sacramento, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Henry Chao, who has overseen much of the work on healthcare.gov, said much of the "back office" work, including the system to send insurers their payments, has not been completed.
MediConnect CEO Amy Rees Anderson and EVP Business Development Adam Casto participated with Michael O. Leavitt, former Utah governor who also served as secretary of Health and Human Services; Utah Senator Orrin Hatch; Utah Governor Gary Herbert; Harvard Business School Professor and best-selling author Clayton Christensen; along with other U.S. senators, congressmen, major university executives, and marquee industry leaders in the 2009 National Summit on Personalized Health Care: Fostering Transformative Innovation.
Neuralstem, Inc. has announced its spinal cord stem cell trial to treat Amyotrophic Lateral Sclerosis (ALS) is on clinical hold and that the Federal Drug Administration (FDA) has provided the Company with specific comments, questions and recommendations for modifications to its protocol.
The new 4th Edition of Practical Neurology, the respected "real-life" guide to diagnosing and managing neurologic disorders, has been completely rewritten to known neurologist and chair of the Department of Neurology of Loyola University Chicago Stritch School of Medicine.
Oncology researchers studying high-risk children's cancers have identified a protein that offers a likely target for immunotherapy-harnessing the immune system in medical treatments. In cell cultures and animal models, a potent drug attached to an antibody selectively zeroes in on cancer cells without harming healthy cells.
› Verified 4 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Henry Chao, who has overseen much of the work on healthcare.gov, said much of the "back office" work, including the system to send insurers their payments, has not been completed.
MediConnect CEO Amy Rees Anderson and EVP Business Development Adam Casto participated with Michael O. Leavitt, former Utah governor who also served as secretary of Health and Human Services; Utah Senator Orrin Hatch; Utah Governor Gary Herbert; Harvard Business School Professor and best-selling author Clayton Christensen; along with other U.S. senators, congressmen, major university executives, and marquee industry leaders in the 2009 National Summit on Personalized Health Care: Fostering Transformative Innovation.
Neuralstem, Inc. has announced its spinal cord stem cell trial to treat Amyotrophic Lateral Sclerosis (ALS) is on clinical hold and that the Federal Drug Administration (FDA) has provided the Company with specific comments, questions and recommendations for modifications to its protocol.
The new 4th Edition of Practical Neurology, the respected "real-life" guide to diagnosing and managing neurologic disorders, has been completely rewritten to known neurologist and chair of the Department of Neurology of Loyola University Chicago Stritch School of Medicine.
Oncology researchers studying high-risk children's cancers have identified a protein that offers a likely target for immunotherapy-harnessing the immune system in medical treatments. In cell cultures and animal models, a potent drug attached to an antibody selectively zeroes in on cancer cells without harming healthy cells.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cameron Lewis Jones, MD 155 N Fresno St, Fresno, CA 93701-2302 Ph: (559) 499-6440 | Dr Cameron Lewis Jones, MD 155 N Fresno St, Fresno, CA 93701-2302 Ph: (559) 499-6440 |
News Archive
Henry Chao, who has overseen much of the work on healthcare.gov, said much of the "back office" work, including the system to send insurers their payments, has not been completed.
MediConnect CEO Amy Rees Anderson and EVP Business Development Adam Casto participated with Michael O. Leavitt, former Utah governor who also served as secretary of Health and Human Services; Utah Senator Orrin Hatch; Utah Governor Gary Herbert; Harvard Business School Professor and best-selling author Clayton Christensen; along with other U.S. senators, congressmen, major university executives, and marquee industry leaders in the 2009 National Summit on Personalized Health Care: Fostering Transformative Innovation.
Neuralstem, Inc. has announced its spinal cord stem cell trial to treat Amyotrophic Lateral Sclerosis (ALS) is on clinical hold and that the Federal Drug Administration (FDA) has provided the Company with specific comments, questions and recommendations for modifications to its protocol.
The new 4th Edition of Practical Neurology, the respected "real-life" guide to diagnosing and managing neurologic disorders, has been completely rewritten to known neurologist and chair of the Department of Neurology of Loyola University Chicago Stritch School of Medicine.
Oncology researchers studying high-risk children's cancers have identified a protein that offers a likely target for immunotherapy-harnessing the immune system in medical treatments. In cell cultures and animal models, a potent drug attached to an antibody selectively zeroes in on cancer cells without harming healthy cells.
› Verified 4 days ago
Michelle Lea Storkan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 | |
Harminder S Longia, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2615 E Clinton Ave, Fresno, CA 93703 Phone: 559-225-6100 | |
Dr. Jessie Werner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 | |
Megann Forrest Young, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 Fax: 559-499-6441 | |
Geoffrey R Stroh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 Fax: 559-499-6441 | |
Marc Stanley Shalit, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6439 Fax: 559-499-6441 | |
Dr. Patil Armenian, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 |